-
Mashup Score: 0Home | Fierce JPM Week - 2 year(s) ago
We might have thought the COVID-19 pandemic would be over by year-end 2021, but experts now say—and the omicron variant suggests—the virus will likely always be with us. What pandemic lessons has the industry learned that can help tackle longtime challenges—such as speeding up drug development, adding new diversity into clinical trials, launching new products and, of course,…
Source: www.fiercejpmweek.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Home | Fierce JPM Week - 2 year(s) ago
We might have thought the COVID-19 pandemic would be over by year-end 2021, but experts now say—and the omicron variant suggests—the virus will likely always be with us. What pandemic lessons has the industry learned that can help tackle longtime challenges—such as speeding up drug development, adding new diversity into clinical trials, launching new products and, of course,…
Source: www.fiercejpmweek.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Home | Fierce JPM Week - 2 year(s) ago
We might have thought the COVID-19 pandemic would be over by year-end 2021, but experts now say—and the omicron variant suggests—the…
Source: www.fiercejpmweek.comCategories: General Medicine News, Latest HeadlinesTweet
The #JPM22 conversations continue this week with our virtual #FierceJPMWeek Jan. 18-20. Find the lineup and sign up here: https://t.co/ZDeKBKHoee